[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[no subject]


  • From: Stuart.McLean@utas.edu.au
  • Date: Wed, 22 May 2002 08:40:43 -0400 (EDT)

<5.1.0.14.0.20020522114426.00a0dc70@postoffice.sandybay.utas.edu.au>
To: indices@usa.healthnet.org
Subject: INDICES> Source of metriphonate?
Sender: owner-indices@usa.healthnet.org
Precedence: bulk
Reply-To: indices@usa.healthnet.org

INDICES> Source of metriphonate?
----------------------------------------
[rerouted from E-drug due to technical content; WB]

Dear e-druggers,

The major hospital in Hobart has a patient with praziquantel resistant
schistosomiasis, presumably caused by S. haematobium. Metriphonate
("Vansil"), which is manufactured by Pfizer but unavailable in Australia,
is indicated but we have been unable to find a supplier. Pfizer Australia
have been unable to find out whether it is still marketed elsewhere,
although they are still trying.

Any suggestions as to sourcing the drug, or alternative treatments?

Best wishes,

Stuart McLean
Tasmanian School of Pharmacy
Stuart McLean
School of Pharmacy
University of Tasmania
GPO Box 252-26
Hobart Tasmania 7001
AUSTRALIA
Stuart.McLean@utas.edu.au

[Praziquantel resistance? That is worrying!
Metriphonate (BAN) or metrifonate (INN) only works on S.Haematobium, so
please ensure the patient has that parasite, and not S.Mansoni. Suggestions
please direct to Stuart.McLean@utas.edu.au. WB]

--
To send a message to Indices, write to: indices@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe indices OR unsubscribe indices
To contact a person, send a message to: indices-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/indices.html